DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · IEX Real-Time Price · USD
-0.120 (-4.78%)
Jun 14, 2024, 9:30 AM EDT - Market open

DiaMedica Therapeutics Statistics

Total Valuation

DMAC has a market cap or net worth of $89.22 million. The enterprise value is $43.08 million.

Market Cap 89.22M
Enterprise Value 43.08M

Important Dates

The last earnings date was Wednesday, May 8, 2024, after market close.

Earnings Date May 8, 2024
Ex-Dividend Date n/a

Share Statistics

DMAC has 37.96 million shares outstanding. The number of shares has increased by 43.51% in one year.

Shares Outstanding 37.96M
Shares Change (YoY) +43.51%
Shares Change (QoQ) -0.14%
Owned by Insiders (%) 26.64%
Owned by Institutions (%) 24.00%
Float 23.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.92
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.14, with a Debt / Equity ratio of 0.01.

Current Ratio 18.14
Quick Ratio 17.93
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -36.20% and return on invested capital (ROIC) is -45.98%.

Return on Equity (ROE) -36.20%
Return on Assets (ROA) -34.50%
Return on Capital (ROIC) -45.98%
Revenue Per Employee n/a
Profits Per Employee -$1.07M
Employee Count 18
Asset Turnover n/a
Inventory Turnover n/a


In the past 12 months, DMAC has paid $43,000 in taxes.

Income Tax 43,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -27.38% in the last 52 weeks. The beta is 1.73, so DMAC's price volatility has been higher than the market average.

Beta (1Y) 1.73
52-Week Price Change -27.38%
50-Day Moving Average 2.79
200-Day Moving Average 2.75
Relative Strength Index (RSI) 33.35
Average Volume (30 Days) 37,930

Short Selling Information

The latest short interest is 130,935, so 0.34% of the outstanding shares have been sold short.

Short Interest 130,935
Short Previous Month 128,561
Short % of Shares Out 0.34%
Short % of Float 0.55%
Short Ratio (days to cover) 3.32

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -21.49M
Pretax Income -19.23M
Net Income -19.27M
EBITDA -19.13M
EBIT -19.23M
Earnings Per Share (EPS) -$0.56
Full Income Statement

Balance Sheet

The company has $46.52 million in cash and $380,000 in debt, giving a net cash position of $46.14 million or $1.22 per share.

Cash & Cash Equivalents 46.52M
Total Debt 380,000
Net Cash 46.14M
Net Cash Per Share $1.22
Equity / Book Value 46.35M
Book Value Per Share 1.22
Working Capital 44.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$20.29 million and capital expenditures -$26,000, giving a free cash flow of -$20.32 million.

Operating Cash Flow -20.29M
Capital Expenditures -26,000
Free Cash Flow -20.32M
FCF Per Share -$0.54
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -43.51%
Shareholder Yield -43.51%
Earnings Yield -21.60%
FCF Yield -22.77%

Analyst Forecast

The average price target for DMAC is $7.00, which is 192.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.00
Price Target Difference 192.89%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on November 15, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date Nov 15, 2018
Split Type Reverse
Split Ratio 1:20


Altman Z-Score n/a
Piotroski F-Score 2